Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab
NCT02186886
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Ulcerative Colitis
Interventions
DRUG:
Golimumab
Sponsor
Kliniken im Naturpark Altmuehltal